<DOC>
	<DOCNO>NCT01833377</DOCNO>
	<brief_summary>This study aim investigate applicability caraway ( black cumin ) intake treatment obesity . So , randomize placebo control clinical trial conduct examine applicability caraway product term safety efficacy .</brief_summary>
	<brief_title>Effect Consumption Caraway Treatment Obesity</brief_title>
	<detailed_description>A randomized placebo-controlled clinical trial , do 120 healthy overweight obese woman age 20-55 Iran . data collect trough questionaires , interview physical examination . required parameter include anthropometric index , body composition vital parameter ( heart rate blood pressure ) full blood parameter , measure intervention . volunteer randomize test control group ask consume either caraway sample placebo 12 intervention week . outcome measure assess primary secondary data baseline week 12 ( 3 month ) .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<criteria>overweight obese woman ( BMI &gt; 25 ) age 2055 year old healthy subject Pregnant lactate woman Thyroid disease type I II diabetes mellitus hypertension ( systolic BP 140 and/or diastolic BP 90 ) endocrine dysfunction impair liver function chronic renal disease cardiovascular disease primary dyslipidemia myopathy patient use drug affect metabolism appetite maintain weight loss precede 3 month meal eat regular interval participation another investigation study within past 30 day history alcohol drug abuse within past year smoke history sleep disorder clinical depression psychiatric condition abnormal obese allergy sensitivity 'active ' 'placebo ' product ingredient</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>obesity</keyword>
	<keyword>overweight</keyword>
	<keyword>BMI</keyword>
</DOC>